Q&A

LNPs vs. Conventional Liposomes: A Short Review Of Core Structural And Manufacturing Differences

Cell&Gene Article #18 - Liposome

An interview with Jay Natarajan, Ph.D., Director R&D, Evonik Health Care

Those who think that liposomes and lipid nanoparticles (LNPs) are interchangeable terms for the same drug delivery technology would be wrong. Key differences exist not only in their target applications, but their actual morphology, composition and manufacturing process. In this interview with Dr. Jay Natarajan, one of Evonik’s formulation and manufacturing experts for LNPs and liposomes, some of these differences are reviewed.

VIEW THE Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online